Michael Gelband’s PRA Health Sciences, Inc. PRAH Stock Holding History

Michael Gelband’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-195,151	Closed	-$32.2M	–	2926
2021 Q2	$32.2M	Buy	195,151 +193,722	+13,556%	+$32.3M	0.36%	21
2021 Q1	$219K	Buy	+1,429	New	+$194K	﹤0.01%	1838
2020 Q3	–	Sell	-5,488	Closed	-$534K	–	2409
2020 Q2	$534K	Buy	+5,488	New	+$511K	0.01%	1051
2020 Q1	–	Sell	-10,104	Closed	-$1.12M	–	1847
2019 Q4	$1.12M	Buy	10,104 +2,280	+29%	+$235K	0.02%	511
2019 Q3	$776K	Buy	7,824 +5,424	+226%	+$539K	0.03%	475
2019 Q2	$238K	Buy	+2,400	New	+$229K	0.01%	815
2019 Q1	–	Sell	-2,651	Closed	-$244K	–	797
2018 Q4	$244K	Buy	+2,651	New	+$268K	0.02%	228

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

Michael Gelband's PRAH Position: Q3 2021 in Review

Michael Gelband sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 195,151 shares — an estimated $32.2M sold.

Michael Gelband first reported a position in PRAH in Q4 2018 and held it in 7 quarters. The position peaked at $32.2M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Michael Gelband reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Michael Gelband sold 195,151 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $32.2M.
Michael Gelband first reported a position in PRA Health Sciences, Inc. in Q4 2018 and held it in 7 quarters.
Michael Gelband's PRA Health Sciences, Inc. position peaked at $32.2M in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on ExodusPoint Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.